| abstract |
COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT OR STEREOISEMERS OF THE SAME, PHARMACEUTICAL COMPOSITION, CANCER TREATMENT OR PREVENTION, AND METHOD OF USE OF THE COMPOUND. The present invention relates to 5H-benzo [4,5] eiclohepta [1,2-b] pyridine derivatives which are useful for the treatment of cell proliferative diseases, for the treatment of disorders associated with MET activity and for MET receptor receptor tyrosine kinase inhibition. The invention also relates to compositions which comprise such compounds and methods of using them to treat mammalian cancer. |